<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>141-CURARES.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="CURARES" code="M03A-001" /></DRUG1>
<DRUG2>
<CLASS name="AMINOGLYCOSIDES" code="J01GB-001" /></DRUG2>
<DESCRIPTION>Increase of the effects of the curares when the antibiotic is administered by parenteral and/or peritoneal route before, during, or after the curarizing agent.</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>141-CURARES.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="CURARES" code="M03A-001" /></DRUG1>
<DRUG2>
<DRUG name="COLISTIN" rxcui="2709">
<ATC code="J01XB01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the effects of the curares when the antibiotic is administered by parenteral and/or peritoneal route before, during, or after the curarizing agent</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>141-CURARES.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="CURARES" code="M03A-001" /></DRUG1>
<DRUG2>
<CLASS name="LINCOSANIDES" code="J01FF0" /></DRUG2>
<DESCRIPTION>Increase of the effects of the curares when the antibiotic is administered by parenteral and/or peritoneal route before, during, or after the curarizing agent</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>141-CURARES.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="CURARES" code="M03A-001" /></DRUG1>
<DRUG2>
<DRUG name="POLYMYXIN B" rxcui="8536">
<ATC code="A07AA05" />
<ATC code="J01XB02" />
<ATC code="S01AA18" />
<ATC code="S02AA11" />
<ATC code="S03AA03" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the effects of the curares when the antibiotic is administered by parenteral and/or peritoneal route before, during, or after the curarizing agent</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
</INTERACTIONS>
